ATE140626T1 - Impfstoff gegen infektionen durch neisseria meningitidis - Google Patents

Impfstoff gegen infektionen durch neisseria meningitidis

Info

Publication number
ATE140626T1
ATE140626T1 AT92921362T AT92921362T ATE140626T1 AT E140626 T1 ATE140626 T1 AT E140626T1 AT 92921362 T AT92921362 T AT 92921362T AT 92921362 T AT92921362 T AT 92921362T AT E140626 T1 ATE140626 T1 AT E140626T1
Authority
AT
Austria
Prior art keywords
receptor
antiserum
recognised
pct
meningitidis
Prior art date
Application number
AT92921362T
Other languages
English (en)
Inventor
Marie-Jose Quentin-Millet
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Application granted granted Critical
Publication of ATE140626T1 publication Critical patent/ATE140626T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/871—Neisseria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92921362T 1991-10-03 1992-09-29 Impfstoff gegen infektionen durch neisseria meningitidis ATE140626T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9112177A FR2682041B1 (fr) 1991-10-03 1991-10-03 Vaccin contre les infections a neisseria meningitidis.

Publications (1)

Publication Number Publication Date
ATE140626T1 true ATE140626T1 (de) 1996-08-15

Family

ID=9417549

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921362T ATE140626T1 (de) 1991-10-03 1992-09-29 Impfstoff gegen infektionen durch neisseria meningitidis

Country Status (14)

Country Link
US (1) US5618541A (de)
EP (1) EP0560968B1 (de)
JP (1) JPH06503365A (de)
AT (1) ATE140626T1 (de)
AU (1) AU662176B2 (de)
CA (1) CA2097056A1 (de)
DE (1) DE69212459T2 (de)
DK (1) DK0560968T3 (de)
ES (1) ES2090696T3 (de)
FI (1) FI107233B (de)
FR (1) FR2682041B1 (de)
HU (1) HU219673B (de)
NO (1) NO306538B1 (de)
WO (1) WO1993006861A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682114B1 (fr) * 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
ES2270420T3 (es) * 1993-11-08 2007-04-01 Sanofi Pasteur Limited Genes receptores de la transferrina de haemophilus.
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
FR2739624B1 (fr) * 1995-10-10 1997-12-05 Pasteur Merieux Serums Vacc Nouvelle sous-unite tbp2 de neisseria meningitidis
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
US6087036A (en) 1997-07-25 2000-07-11 3M Innovative Properties Company Thermal management system and method for a solid-state energy storing device
FR2767060B1 (fr) * 1997-08-07 2000-02-11 Pasteur Merieux Serums Vacc Vaccin meningocoque comportant la valence de souche bz83
RU2347813C2 (ru) * 1997-11-06 2009-02-27 Чирон С.П.А. Антигены нейссерий
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
GB9823978D0 (en) 1998-11-02 1998-12-30 Microbiological Res Authority Multicomponent meningococcal vaccine
US10967045B2 (en) 1998-11-02 2021-04-06 Secretary of State for Health and Social Care Multicomponent meningococcal vaccine
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
CA2503871C (en) 2002-11-01 2012-12-11 Glaxosmithkline Biologicals S.A. An immunogenic composition for generating an immune response against polio virus
ES2397923T3 (es) 2003-10-02 2013-03-12 Novartis Ag Vacunas líquidas para múltiples serogrupos meningocócicos
AU2004277342B2 (en) 2003-10-02 2010-12-16 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
ES2337309T5 (es) 2006-06-12 2013-07-30 Glaxosmithkline Biologicals S.A. Vacuna
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
EP2544714A1 (de) 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Impfstoffzusammensetzung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same

Also Published As

Publication number Publication date
FI107233B (fi) 2001-06-29
EP0560968B1 (de) 1996-07-24
US5618541A (en) 1997-04-08
FR2682041B1 (fr) 1994-01-14
DE69212459T2 (de) 1996-12-05
AU2762492A (en) 1993-05-03
NO306538B1 (no) 1999-11-22
DK0560968T3 (da) 1996-11-25
NO932010L (no) 1993-06-02
NO932010D0 (no) 1993-06-02
FI932491A0 (fi) 1993-06-01
HUT69980A (en) 1995-09-28
EP0560968A1 (de) 1993-09-22
HU219673B (hu) 2001-06-28
FI932491L (fi) 1993-06-01
AU662176B2 (en) 1995-08-24
ES2090696T3 (es) 1996-10-16
JPH06503365A (ja) 1994-04-14
FR2682041A1 (fr) 1993-04-09
DE69212459D1 (de) 1996-08-29
CA2097056A1 (en) 1993-04-04
WO1993006861A1 (fr) 1993-04-15

Similar Documents

Publication Publication Date Title
DE69212459D1 (de) Impfstoff gegen infektionen durch neisseria meningitidis
FR2727015B1 (fr) Compositions pharmaceutiques liquides a base d'ondansetron
DK0733046T3 (da) Benzoylguanidiner, deres fremstilling og anvendelse i medikamenter
KR880000098A (ko) 콘드로이틴 설페이트 면역자극 조성물
DK0597088T3 (da) Nye imidazolderivater, deres fremstilling og terapeutiske anvendelser
ATE171066T1 (de) Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält
DE69219901D1 (de) Adenosinderivate, Verfahren zu deren Herstellung und pharmazeutische Mittel
FR2765107B1 (fr) Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
FI932490A0 (fi) Underenhetsvaccin mot Neisseria meningitidis-infektioner och motsvarande underenheter i rent tillstaond
CA2528312A1 (en) Methods of managing the symptoms of premenstrual syndrome
JPH0278625A (ja) 花粉症治療薬

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification